These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2960763)

  • 1. CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review.
    Wilson JG; Andriopoulos NA; Fearon DT
    Immunol Res; 1987; 6(3):192-209. PubMed ID: 2960763
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus.
    Wilson JG; Ratnoff WD; Schur PH; Fearon DT
    Arthritis Rheum; 1986 Jun; 29(6):739-47. PubMed ID: 2941021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Fc Receptor and C4.C3 receptors of the granulocytes from patients with systemic lupus erythematosus.
    Shingu M; Todoroki T; Sakai K; Nobunaga M
    J Rheumatol; 1981; 8(6):910-6. PubMed ID: 7328566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced numbers of complement receptor type 1 on erythrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Hammond A; Rudge AC; Loizou S; Bowcock SJ; Walport MJ
    Arthritis Rheum; 1989 Mar; 32(3):259-64. PubMed ID: 2522783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
    Verma J; Arora V; Marwaha V; Kumar A; Das N
    Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CR1 deficiency in SLE: acquired or genetic?
    Uko G; Dawkins RL; Kay P; Christiansen FT; Hollingsworth PN
    Clin Exp Immunol; 1985 Nov; 62(2):329-36. PubMed ID: 2935336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement receptors.
    Holers VM
    Year Immunol; 1989; 4():231-40. PubMed ID: 2538973
    [No Abstract]   [Full Text] [Related]  

  • 9. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
    Paccaud JP; Carpentier JL; Schifferli JA
    Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.
    Yoshida K; Yukiyama Y; Hirose S; Miyamoto T
    Clin Exp Immunol; 1985 Jun; 60(3):613-21. PubMed ID: 3160514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
    Yoshida K; Yukiyama Y; Miyamoto T
    J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus.
    Ho A; Barr SG; Magder LS; Petri M
    Arthritis Rheum; 2001 Oct; 44(10):2350-7. PubMed ID: 11665976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus regulates activation and processing of the third component of complement.
    Mold C; Bradt BM; Nemerow GR; Cooper NR
    J Exp Med; 1988 Sep; 168(3):949-69. PubMed ID: 2844953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of C3b receptors in the differentiation of discoid lupus erythematosus and systemic lupus erythematosus.
    Tausk F; Harpster E; Gigli I
    Arthritis Rheum; 1990 Jun; 33(6):888-92. PubMed ID: 2141982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
    J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
    Iida K; Mornaghi R; Nussenzweig V
    J Exp Med; 1982 May; 155(5):1427-38. PubMed ID: 6978375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlative expression of C3b receptors in the glomerulus and on erythrocytes.
    Minota S; Terai C; Nojima Y; Takano K; Yamada A; Miyakawa Y; Takaku F
    Clin Immunol Immunopathol; 1986 Jan; 38(1):85-92. PubMed ID: 2934197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
    Taylor RP; Burge J; Horgan C; Shasby DM
    J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare.
    Birmingham DJ; Gavit KF; McCarty SM; Yu CY; Rovin BH; Nagaraja HN; Hebert LA
    Clin Exp Immunol; 2006 Feb; 143(2):274-80. PubMed ID: 16412051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.